Edupreneur Editorial Team14 April 2025
Swiss pharmaceutical company Sandoz has filed an antitrust lawsuit in the United States against biotech giant Amgen, accusing it of unfairly blocking competition for its top-selling arthritis medication, Enbrel (etanercept). Sandoz claims that although its biosimilar version of the drug, Erelzi, was approved by the U.S. Food and Drug Administration (FDA) back in 2016, it […]
